Morphic Holding Inc (NASDAQ:MORF)
| 22.88 Delayed Data As of Sep 29 |  +0.39 / +1.73%Today’s Change | 19.80 Today|||52-Week Range 63.08 | -14.47% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $1.8B |
Company Description
Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
Contact Information
Morphic Holding, Inc. 35 Gatehouse Drive A2 Waltham Massachusetts 02451 | P:(781) 996-0955 Investor Relations: -- |
Employees
Shareholders
| Other institutional | 40.09% |
| Mutual fund holders | 39.58% |
| Individual stakeholders | 30.45% |
Top Executives
| Praveen P. Tipirneni | Chief Executive Officer & Director |
| Bruce N. Rogers | President |
| Marc Schegerin | Chief Operating & Financial Officer |
| Brihad Abhyankar | Vice President-Clinical Development |
| Blaise Lippa | Chief Scientific Officer |
